Philogen (Italy)

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin

Laura Borsi, Enrica Balza, Marco Bestagno et al. · International Journal of Cancer · 2002 · 355 citations · Full text

Ed‐b Domain, Immunology, Immunoediting +20

Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer.

Monica Santimaria, G Moscatelli, Giuseppe Viale et al. · PubMed · 2003 · 294 citations

The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano et al. · European Journal of Cancer · 2010 · 179 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +7

Design, construction, and characterization of a large synthetic human antibody phage display library

Michela Silacci, Simon Brack, Giulia Schirru et al. · PROTEOMICS · 2005 · 175 citations

Engineering, Immunology, Molecular Biology +16

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo et al. · Cancer Immunology Immunotherapy · 2015 · 173 citations · Full text

Medicine, Melanoma, Immunology +8